Chandra Bhagat Pharma Limited (BOM:542934)
58.00
0.00 (0.00%)
At close: Jun 19, 2025
Chandra Bhagat Pharma Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2020 |
Cash & Equivalents | 6.65 | 49.64 | 64.4 | 56.81 | 28.21 | Upgrade
|
Short-Term Investments | 1.37 | 1.32 | 1.1 | 2.21 | - | Upgrade
|
Cash & Short-Term Investments | 8.02 | 50.97 | 65.49 | 59.03 | 28.21 | Upgrade
|
Cash Growth | -84.26% | -22.18% | 10.96% | 109.23% | 253.49% | Upgrade
|
Accounts Receivable | 359.46 | 394.47 | 81.86 | 150.04 | 154.18 | Upgrade
|
Other Receivables | - | 2.62 | 0.95 | 0.71 | 0.02 | Upgrade
|
Receivables | 948.49 | 533.84 | 129.66 | 192.54 | 228.06 | Upgrade
|
Inventory | 6.92 | 86.77 | 290.77 | 341.57 | 351.39 | Upgrade
|
Prepaid Expenses | - | 1.08 | 0.3 | 0.07 | 0.17 | Upgrade
|
Other Current Assets | 11.07 | 306.54 | 94.67 | 114.06 | 92.27 | Upgrade
|
Total Current Assets | 974.5 | 979.18 | 580.9 | 707.26 | 700.1 | Upgrade
|
Property, Plant & Equipment | 26.22 | 25.22 | 7.28 | 4.73 | 4.23 | Upgrade
|
Long-Term Deferred Tax Assets | 0.69 | 0.21 | - | - | - | Upgrade
|
Long-Term Deferred Charges | - | 6.55 | 9.59 | 12.63 | 13.49 | Upgrade
|
Other Long-Term Assets | 13.89 | 6.89 | 8.07 | - | - | Upgrade
|
Total Assets | 1,015 | 1,018 | 605.83 | 724.62 | 717.81 | Upgrade
|
Accounts Payable | 89.53 | 132.31 | 31.02 | 26.72 | 128.54 | Upgrade
|
Accrued Expenses | - | 2.24 | 9.02 | 10.42 | 19.45 | Upgrade
|
Short-Term Debt | - | 140.58 | 137.39 | 143.85 | 156.34 | Upgrade
|
Current Portion of Long-Term Debt | 185.77 | 9.56 | 12.78 | 13.12 | 19.85 | Upgrade
|
Current Income Taxes Payable | 4.01 | 6.03 | 2.93 | 2.71 | 3 | Upgrade
|
Other Current Liabilities | 413.19 | 419.87 | 76.33 | 183.7 | 1.53 | Upgrade
|
Total Current Liabilities | 692.49 | 710.6 | 269.48 | 380.52 | 328.71 | Upgrade
|
Long-Term Debt | 22.84 | 14.13 | 39.28 | 54.2 | 94.51 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | 0.14 | 0.12 | 0.1 | Upgrade
|
Other Long-Term Liabilities | 0.29 | 3.23 | 22.16 | 23.03 | 35.71 | Upgrade
|
Total Liabilities | 715.61 | 727.96 | 331.05 | 457.87 | 459.03 | Upgrade
|
Common Stock | 75.45 | 75.45 | 75.45 | 75.45 | 75.45 | Upgrade
|
Additional Paid-In Capital | - | - | - | 133.71 | 133.71 | Upgrade
|
Retained Earnings | - | - | - | 57.6 | 49.63 | Upgrade
|
Comprehensive Income & Other | 224.24 | 214.64 | 199.34 | -0 | -0 | Upgrade
|
Shareholders' Equity | 299.69 | 290.09 | 274.79 | 266.76 | 258.79 | Upgrade
|
Total Liabilities & Equity | 1,015 | 1,018 | 605.83 | 724.62 | 717.81 | Upgrade
|
Total Debt | 208.6 | 164.27 | 189.45 | 211.18 | 270.7 | Upgrade
|
Net Cash (Debt) | -200.58 | -113.3 | -123.95 | -152.15 | -242.49 | Upgrade
|
Net Cash Per Share | -26.66 | -15.02 | -16.43 | -20.17 | -32.14 | Upgrade
|
Filing Date Shares Outstanding | 7.52 | 7.55 | 7.55 | 7.55 | 7.55 | Upgrade
|
Total Common Shares Outstanding | 7.52 | 7.55 | 7.55 | 7.55 | 7.55 | Upgrade
|
Working Capital | 282.01 | 268.58 | 311.42 | 326.75 | 371.39 | Upgrade
|
Book Value Per Share | 39.84 | 38.45 | 36.42 | 35.35 | 34.30 | Upgrade
|
Tangible Book Value | 299.69 | 290.09 | 274.79 | 266.76 | 258.79 | Upgrade
|
Tangible Book Value Per Share | 39.84 | 38.45 | 36.42 | 35.35 | 34.30 | Upgrade
|
Land | - | 2.74 | 2.74 | 2.74 | 2.74 | Upgrade
|
Machinery | - | 31.24 | 8.42 | 4.76 | 6.11 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.